Management of recurrent and refractory Cushing disease
Author:
- 19 August 2008
- journal article
- research article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 4 (10) , 560-568
Abstract
Cushing disease is an uncommon disorder frequently caused by microadenoma. Although treatment has been greatly improved by the evolution of radiotherapy, radiosurgery and medications, in a substantial proportion of cases the disease is refractory or recurrent. This Review presents and discusses the various management options for such patients. Cushing disease is most frequently caused by pituitary adenomas that secrete adrenocorticotrophic hormone. Transsphenoidal surgery is the treatment of choice in patients with these tumors because of reported remission rates of 69–93%. More challenging for neurosurgeons and endocrinologists, however, is management of the remaining patients whose Cushing disease is refractory to initial transsphenoidal surgery or recurs after initial remission. Here, we review the treatment options and latest surgical, medical, and radiosurgical advances for patients who have persistent or recurrent Cushing disease after transsphenoidal surgery.Keywords
This publication has 43 references indexed in Scilit:
- Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2008
- Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 yearsJournal of Neurosurgery, 2008
- Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2007
- Mortality in Patients Treated for Cushing’s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary MacroadenomaThe Journal of Clinical Endocrinology & Metabolism, 2007
- Early Morning Cortisol Levels as a Predictor of Remission After Transsphenoidal Surgery for Cushing’s DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2006
- Long‐term remission rates after pituitary surgery for Cushing's disease: the need for long‐term surveillanceClinical Endocrinology, 2005
- Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term ResultsThe Journal of Clinical Endocrinology & Metabolism, 2004
- Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression testJournal of Neurosurgery, 2003
- Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?Clinical Endocrinology, 2001
- Transsphenoidal Microsurgery for Cushing DiseaseAnnals of Internal Medicine, 1988